MADISON, Wis.--(BUSINESS WIRE)--Usona Institute has received Breakthrough Therapy Designation from the US Food and Drug Administration (FDA) for psilocybin in the treatment of major depressive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results